ARCHIVES

DCE Board Recompetition Concepts

This article is from The Cancer Letter archive.

Vol. 13 No. 29 | July 17, 1987

Download PDF Visit The Full Archive

Related Articles

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004